Clinical and metabolic effects of the monophasic gestodene/ethinylestradiol pill for contraception during adolescence
G Creatsas, P Adamopoulos, N Eleftheriou… - Adolescent and pediatric …, 1991 - Elsevier
The clinical and metabolic effects of the gestodene-containing oral contraceptive (OC) was
tested in 50 normal adolescents who received the monophasic 75 mg gestodene/30 μg …
tested in 50 normal adolescents who received the monophasic 75 mg gestodene/30 μg …
Inhibition of ovulation by a triphasic gestodene-containing oral contraceptive
J Spona, U Lachnit-Fixson, B Düsterberg… - Advances in …, 1993 - Springer
The minimal effective dose of gestodene for inhibition of ovulation was studied in 30 female
volunteers. Daily doses of 10 μg to 50 μg gestodene were given orally for 21 days. A control …
volunteers. Daily doses of 10 μg to 50 μg gestodene were given orally for 21 days. A control …
Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein …
W Kuhnz, A Baumann, T Staks, L Dibbelt, R Knuppen… - Contraception, 1993 - Elsevier
The pharmacokinetics of gestodene (GEST) and ethinylestradiol (EE 2) were determined in
14 healthy women (age 18 to 32 years) during a treatment period of three months with a new …
14 healthy women (age 18 to 32 years) during a treatment period of three months with a new …
Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents
K Brill, J Schnitker, M Albring - Advances in contraception, 1994 - Springer
This clinical investigation of a low-dose, monophasic gestodene-containing oral
contraceptive (75 μg gestodene/30 μg ethinylestradiol), investigated contraceptive efficacy …
contraceptive (75 μg gestodene/30 μg ethinylestradiol), investigated contraceptive efficacy …
The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel
M Orme, DJ Back, S Ward, S Green - Contraception, 1991 - Elsevier
Single doses of ethynylestradiol (30 μg) were given alone and in combination with either
gestodene (75 μg) or desogestrel (150 μg) to 10 healthy female volunteers. The doses of …
gestodene (75 μg) or desogestrel (150 μg) to 10 healthy female volunteers. The doses of …
Evaluation of a new generation of oral contraceptives
L Speroff, A DeCherney - Obstetrics & Gynecology, 1993 - journals.lww.com
Objective: To assess the differences and similarities in efficacy, safety, and metabolic effects
of oral contraceptives (OCs) containing the new progestins desogestrel, gestodene, and …
of oral contraceptives (OCs) containing the new progestins desogestrel, gestodene, and …
A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene in Latin American …
S Bassol, G Alvarado, RG Arreola, C Celis-Gonzalez… - Contraception, 2003 - Elsevier
This prospective, multicenter study was conducted to evaluate the contraceptive reliability,
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …
Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene
HW Halbe, NR De Melo, L Bahamondes… - … European Journal of …, 1998 - Taylor & Francis
Objective To assess the contraceptive efficacy, cycle control and acceptability of two
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …
Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations
FZ Stanczyk, DF Archer - Contraception, 2014 - Elsevier
Combined progestin–estrogen pills are an established and reliable contraceptive option
used by women worldwide. Combined oral contraceptives (COCs) containing the progestins …
used by women worldwide. Combined oral contraceptives (COCs) containing the progestins …